How has been the historical performance of Nexus Surgical?

Answer:The historical performance of Nexus Surgical shows a significant upward trend in net sales and profitability over the past few years, culminating in the fiscal year ending March 2025.

Breakdown:
Nexus Surgical's net sales have increased from 1.55 Cr in March 2023 to 5.72 Cr in March 2025, indicating strong growth. Total operating income followed a similar trend, rising from 1.55 Cr in March 2023 to 5.72 Cr in March 2025. The company's total expenditure also grew, reaching 5.06 Cr in March 2025, up from 1.34 Cr in March 2023. Despite this increase, the operating profit (PBDIT) improved from 0.21 Cr in March 2023 to 0.67 Cr in March 2025, reflecting a healthier operating profit margin of 11.54% in March 2025 compared to 13.55% in March 2023. Profit before tax also rose from 0.23 Cr in March 2023 to 0.67 Cr in March 2025, with profit after tax increasing from 0.17 Cr to 0.50 Cr over the same period. The earnings per share (EPS) improved significantly from 0.31 in March 2023 to 0.91 in March 2025. On the balance sheet, total assets increased from 0.91 Cr in March 2023 to 2.27 Cr in March 2025, while total liabilities rose from 0.91 Cr to 2.27 Cr in the same timeframe. The company has maintained zero debt throughout this period. Overall, Nexus Surgical's financial performance demonstrates a positive trajectory in sales, profitability, and asset growth.